Form 4 for INSP Inspire Medical Systems, Inc.
Accepted 2021-08-20 00:00:00 ET · period of report 2021-08-18 · accession 0001104659-21-108154 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-08-20 | 2021-08-18 | INSP | Melenikiotou Georgia | Dir | M - OptEx | $93.14 | +852 | 1,132 | +304% | +$79.4K |
| DM | 2021-08-20 | 2021-08-18+ | INSP | Melenikiotou Georgia | Dir | S - Sale+OE | $207.06 | -992 | 140 | -88% | -$205.4K |
| D | 2021-08-20 | 2021-08-18 | INSP | Melenikiotou Georgia | Dir | A - Grant | $0.00 | -852 | 2,982 | -22% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-08-18 | M | A | 852 | $93.14 | 1,132 | D | — | — | |
| 2 | Common | Common Stock | 2021-08-18 | S | D | 852 | $207.08 | 280 | D | — | — | (F1) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $206.96 to $207.20. The reporting person undertakes to provide the Company, any security holder of Inspire Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 3 | Common | Common Stock | 2021-08-19 | S | D | 140 | $206.97 | 140 | D | — | — | |
| 4 | Derivative | Employee Stock Option (Right to Buy) | 2021-08-18 | A | D | 852 | $0.00 | 2,982 | D | $93.14 · — to 2030-07-08 | 852 Common Stock | (F2) The original 3,834 shares underlying the option have vested or will vest and become exercisable in three equal annual installments that began on July 8, 2021, subject to the Non-Employee Director continuing in service through each applicable vesting date. |